G. Talbot

Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections

W. Prince, Z. Ivezić-Schoenfeld, C. Lell, 2013, Antimicrobial Agents and Chemotherapy.

A Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in the

W. Prince, C. Lell, K. Tack, 2013 .

A Phase II clinical study of BC-3781 , a pleuromutilin antibiotic , in the 1 treatment of patients with acute bacterial skin and skin structure 2 infection

C. Lell, K. Tack, R. Novak, 2013 .

Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group.

G. Talbot, J. Morganroth, P. Jaillon, 1996, The Journal of antimicrobial chemotherapy.